Clinical Trials Browser

Phase 2 × Active not recruiting × Bilateral Breast Carcinoma × Clear all

NCT00877500 2025-11-10

Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy

Phase 2 Active not recruiting

Bilateral Breast Carcinoma